ReviewCurrent medicinal chemistry2024

The Treatment of a New Entity in Advanced Non-small Cell Lung Cancer: MET Exon 14 Skipping Mutation.

Danilo Rocco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.